Clinical Nutrition Market (2025 - 2033)

Clinical Nutrition Market Summary

The global clinical nutrition market size was estimated at USD 32.32 billion in 2024 and is projected to reach USD 55.92 billion by 2033, growing at a CAGR of 6.37% from 2025 to 2033. This growth is driven by the rising prevalence of malnutrition, increasing demand for post-cancer care, and a consumer shift toward plant-based options, along with the launch of such solutions by notable players such as Nutricia and Nestlé.

According to the World Health Organization, around 512 million people could be chronically undernourished by 2030, with 60% of them from Africa. This rising prevalence of malnutrition and undernutrition is expected to significantly drive demand for clinical nutrition solutions, as governments, NGOs, and healthcare providers focus on addressing nutritional deficiencies and improving health outcomes in vulnerable populations. The growing need for specialized nutritional support in both pediatric and adult groups, particularly in low- and middle-income countries, is further accelerating investments in therapeutic nutrition products, fortified supplements, and enteral and parenteral nutrition, positioning clinical nutrition as a critical component in combating the global burden of malnutrition.

There has been a constant increase in the prevalence of chronic diseases, such as Alzheimer's disease, Attention Deficit Hyperactivity Disorder (ADHD), osteoporosis, osteoarthritis, central nervous system disorders, and other diseases that require clinical dietary management. For instance, as per the data published by the Centers for Disease Control and Prevention (CDC) in August 2023, ADHD ranks among the most prevalent mental conditions in children, with approximately 6 million children aged 3 to 17 years having received a diagnosis at some point.

Clinical Nutrition Importance in Special Cases

Emerging Trend in Clinical Nutrition Market: Plant-Based Medical Nutrition

One of the notable trends in the clinical nutrition industry is the growing adoption of plant-based medical nutrition, driven by rising consumer preference for clean, ethical, and culturally inclusive dietary options. Plant-based formulations are increasingly being developed by players such as Nutricia and Nestle to meet the needs of patients at risk of malnutrition, with clinical evidence showing they can improve protein and energy intake, support adherence, and contribute to reducing the carbon footprint of nutritional care. This shift reflects a broader movement toward aligning clinical efficacy with sustainability and patient lifestyle preferences.

Key players driving the Plant-based medical nutrition market:

• Nutricia (Danone)

• Nestle

• MiracleMe

Market Concentration & Characteristics

The chart below illustrates the relationship between market concentration, industry characteristics, and industry participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, impact of regulations, level of partnerships & collaborations activities, degree of innovation, and regional expansion. For instance, the clinical nutrition industry is consolidating steadily, moving towards fragmentation, with many product & service providers entering the market. The degree of innovation, the level of partnerships & collaboration activities, and the impact of regulations on the industry is high. However, the regional expansion observes moderate growth.

The clinical nutrition industry is experiencing a substantial degree of innovation, with companies increasingly focusing on sustainable formulations, patient-centric design, and inclusivity in dietary options. In January 2023, Nutricia launched Fortimel Plant-Based Energy, its first plant-based, nutritionally complete medical nutrition drink made from pea and soy proteins. Such insights reflect a broader industry trend of developing advanced nutritional solutions that meet clinical needs and align with evolving consumer values and sustainability goals.

The level of partnerships and collaborations in the clinical nutrition industry is growing as market players increasingly join forces with healthcare, digital health, and research organizations to expand access and enhance patient outcomes. For instance, in January 2024, Danone partnered with Resilience, a digital oncology firm intent on improving nutritional care for cancer patients.

In the U.S., clinical nutrition is regulated under the provisions of the Federal Food, Drugs, & Cosmetics Act and the Fair Packaging & Labeling Act. Manufacturers are required to comply with all applicable laws as per these acts. According to the Federal Food, Drug, & Cosmetic Act, for a product to be classified as a medical food. On the other hand, the enteral nutrition products in the UK are regulated as FSMP in the UK. Since December 2020, the Food for Specific Purposes has been regulated under Regulation No. 609/2013, retained after Brexit in the UK. The Food Standards Scotland (FSS), the Department of Health & Social Care (DHSC), and the Welsh government govern the country’s FSS. Moreover, the FSMP is regulated under the retained Commission Delegated Regulation 2016/128 and came into law in February 2019, and for infants, it was implemented in February 2020.

The clinical nutrition industry is witnessing moderate regional expansion, driven by the rising prevalence of malnutrition, the growing aging populations, and increasing healthcare investments in emerging economies. Companies are scaling operations, introducing new product portfolios, and partner with regional players to improve accessibility and address diverse cultural and dietary needs. This global reach contributes to the faster adoption of clinical nutrition solutions while supporting equitable access to advanced nutritional care.

Product Insights

The oral nutrition segment led the market with the largest revenue share of 54.3% in 2024. The rising prevalence of malnutrition among the adult population and the increasing instances of obesity and chronic diseases such as cancer and diabetes are some of the major factors boosting the market growth. Market leaders and innovators are involved in novel product launches to enhance productivity, durability, quality, and improve the nutritional value of the food products. Along with the nutritional value, the manufacturers of clinical nutrition products are working to enhance and improve the taste of the products by incorporating different flavors. Due to this, the demand for oral clinical nutrition products is rising, thereby driving the global market.

The parenteral nutrition segment is expected to grow at the fastest CAGR over the forecast period. Development of technically advanced parenteral nutrition (PN) products with barcode assistance, growing preference for PN over enteral nutrition in patients, shorter hospital stays, and reduced risk of infection are some of the factors boosting the product demand, thereby driving the segment growth.

Application Insights

The cancer care segment led the market with the largest revenue share of 15.1% in 2024. The rising prevalence of cancer is the primary factor driving the segment growth. For instance, according to the statistics published by the American Cancer Society Journal in January 2023, around 609,820 people in the U.S. were anticipated to die from cancer in 2023. In addition, by 2040, it is anticipated that the global burden of cancer is expected to surge to approximately 30 million new cases, with the most significant rises expected in low- and middle-income countries. Cancer weakens immunity and leads to energy loss, resulting in malnutrition in 40% to 80% of cases. This affects the response to the treatment as well as increases treatment-related toxicity. Hence, to maintain nutrition and positive nitrogen balance, various types of clinical nutrition, such as tube feeding, are used.

The malabsorption/GI disorder/diarrhea segment is anticipated to grow at the fastest CAGR over the forecast period. Malabsorption typically means difficulty in digesting nutrients that are provided through food. Certain conditions are known to cause malabsorption, such as short bowel syndrome, cystic fibrosis, chronic pancreatitis, and Crohn’s disease. It can also lead to other illnesses if proper nutrients are unavailable in the body. In these cases, enteral nutrition via oral or tube/enteral feeding plays a vital role. It provides the body with necessary nutrients and helps in improving gut immunity.

Sales Channel Insights

The institutional sales channel segment led the market with the largest revenue share of 46.1% in 2024. Institutions that purchase clinical nutrition products include hospitals, long-term care centers, hospices, and disability facilities. The purchase decision of enteral or parenteral nutrition is influenced by doctors. Furthermore, the growing number of private and public institutions and the increasing chronic disease patient population across the globe are propelling the segment.

The online sales channel segment is anticipated to witness at the fastest CAGR during the forecast period. There is a shift in the trend of direct selling to customers via e-commerce platforms. The preference for online purchase of enteral feeding formula is rising owing to the convenience offered by this sales channel. Although consumed under medical surveillance, these products are intended for long-term nutrition management, resulting in growing sales through e-commerce.

Regional Insights

North America dominated the global clinical nutrition market with the largest revenue share of 32.6% in 2024. This can be attributed to the increasing geriatric population, which is more susceptible to chronic diseases, such as gastrointestinal disorders, metabolic disorders, and neurological disorders. According to the United Health Foundation, in 2022, about 17.3% of the population in the U.S. was aged 65 and above. Furthermore, around 56 million elderly people are expected to depend on clinical nutrition to fulfill their nutritional needs in the U.S. by 2030. Moreover, the growing number of premature infants in critical care is a major factor driving market growth. For instance, in 2022, the CDC reported that approximately 10% of infants born in the U.S. were affected by preterm birth.

U.S. Clinical Nutrition Market Trends

The clinical nutrition market in the U.S. accounted for the largest market revenue share in North America in 2024. The increasing prevalence of head & neck cancer across the U.S. is contributing to the adoption of medical foods. For instance, the American Cancer Society, in 2023, reported that approximately 54,540 new cases and 11,580 fatalities were attributed to oral cavity or oropharyngeal cancer in the U.S. Furthermore, rising demand for clinical nutrition formulas such as enteral feeding formulas by end users and the fact that enteral feeding is the safest way to help patients meet their nutritional requirements have positively influenced the market growth in this region.

Europe Clinical Nutrition Market Trends

The clinical nutrition market in Europe is expanding steadily, supported by the region’s aging population, rising prevalence of chronic diseases, and strong focus on advanced nutritional care. For instance, according to a publication by the European Parliament in 2022, Chronic Kidney Disease (CKD) affects around 100 million people in the region and is projected to become the fifth leading cause of global mortality by 2040. This growing disease burden underscores the critical role of clinical nutrition in managing chronic conditions, improving patient outcomes, and reducing healthcare costs, thereby driving demand for specialized nutritional solutions across Europe.

The UK clinical nutrition market is driven by an aging population, increasing prevalence of chronic diseases, and rising hospital admissions requiring nutritional support. The National Health Service (NHS) strongly emphasizes addressing malnutrition, particularly among elderly and long-term care patients, creating consistent demand for enteral and parenteral nutrition products. In addition, the UK’s focus on innovation, adoption of plant-based and sustainable formulations, and integration of clinical nutrition into home care settings are further supporting market expansion.

The clinical nutrition market in Germany is growing due to its aging population, high prevalence of chronic diseases, and strong healthcare infrastructure. Rising demand for enteral and parenteral nutrition, along with increasing adoption of specialized therapies in hospitals and home care, continues to drive market growth.

Asia Pacific Clinical Nutrition Market Trends

The clinical nutrition market in the Asia Pacific is anticipated to witness at the fastest CAGR over the forecast period. The region has a large patient pool and a geriatric population. Lifestyle changes are leading to an increase in the prevalence of various diseases, such as cancer, diabetes, gastrointestinal disorders, and autoimmune diseases. As a result, the demand for clinical nutrition for the dietary management of chronic diseases is expected to increase.

The Japan clinical nutrition market is growing rapidly, due to the country's increasing aging population. According to the data published by the Ministry of Internal Affairs and Communications in October 2023, the number of people aged 65 and above as of September 15, 2023, stood at 36.2 million. Furthermore, supportive legislative changes in the country are also expected to impact the market positively. The Ministry of Health, Labour, and Welfare in Japan has established exclusive enteral and parenteral nutritional clinical guidelines for clinical nutrition. This is expected to drive the market over the forecast period.

The clinical nutrition market in China is growing at a fast pace; its growth is attributed to the increasing geriatric population, the increasing per capita healthcare expenditure, and the prevalence of esophageal cancer. For instance, according to a UN report, the elderly population is expected to increase twofold from 10% in 2017 to 20% by 2037. The rising incidence of neurological diseases, such as Alzheimer’s disease and multiple sclerosis, is further expected to drive the market growth in China.

Latin America Clinical Nutrition Market Trends

The clinical nutrition market in Latin America is anticipated to grow at the substantial CAGR during the forecast period. Constant efforts by the government to improve healthcare access and treatment are expected to drive the market growth in Latin America. In addition, the increasing prevalence of chronic diseases, improving reimbursement scenarios, growing need for nutrition by geriatric & pediatric populations and increasing investments aimed at advancements in the healthcare industry are some of the factors contributing to the market's growth.

Middle East & Africa Clinical Nutrition Market Trends

The clinical nutrition market in the Middle East & Africa is growing, with a high prevalence of malnutrition, a rising burden of chronic diseases, expanding healthcare infrastructure, and a growing elderly population. For instance, according to the Global Nutrition Report, the UAE faces a major nutrition challenge, with 44.2% of women and 30.9% of men aged 18 and older classified as obese

Key Clinical Nutrition Company Insights

Key players in the clinical nutrition industry are adopting innovative strategies, focusing on specialized formulations for chronic diseases, plant-based and sustainable nutrition, and patient-tailored solutions to improve outcomes and adherence. Expansion into home care settings, integration of digital health tools for monitoring nutritional status, and collaborations with healthcare providers and research institutions are further driving adoption and strengthening market presence.

Recent Developments

• In September 2025, Sudeep Pharma Limited acquired Nutrition Supplies Services (NSS), a European premix solutions provider, to expand its global presence in infant formula and clinical nutrition. This acquisition combines NSS’s micronutrient premix expertise with Sudeep’s mineral portfolio and global distribution, improving its ability to deliver science-backed nutrition solutions across Europe, Asia, Africa, and the Middle East.

“This acquisition reflects our commitment to becoming a global leader in specialty nutrition and healthcare ingredients. Together with NSS, we are better positioned to serve evolving customer needs with agility, innovation, and uncompromised quality.”

- Shanil Bhayani, Director at Sudeep Pharma Limited.

• In May 2024, Danone acquired Functional Formularies, a provider of whole food tube feeding solutions in the U.S., from Swander Pace Capital. This acquisition is a strategic component of Danone's Renew Strategy, enhancing the company's Medical Nutrition offerings in the U.S. market by broadening its portfolio of enteral tube feeding products.

“As a global leader in Medical Nutrition, we are delighted to welcome Functional Formularies to Danone. We are confident that with the addition of the greatly differentiated product portfolio of Functional Formularies, which complements our existing Real Food Blends branded range, we are even better positioned to support the nutritional needs of tube-fed families and patients.”

-Juergen Esser, Deputy CEO and CFO

• In May 2024, Neslte and EraCal Therapeutics entered into a research collaboration to identify novel nutraceuticals relevant to controlling food intake. Neslte and EraCal Therapeutics entered into a research collaboration to identify novel nutraceuticals relevant to controlling food intake.

“Nestlé Health Science knows how to develop nutraceutical compounds as first-line treatment for people in need, thanks to their distinguished commitment to cutting-edge science and clinical validation. We are therefore excited to join forces with the world-leading company in the nutritional space and together drive innovation in the metabolic syndrome arena.”

- Josua Jordi, CEO of EraCal.

• In March 2022, Fresenius Kabi received FDA approval for the utilization of its SMOFlipid Lipid Injectable Emulsion in pediatric patients on parenteral nutrition.

Clinical Nutrition Market